The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study.

Vaccination against the human papillomavirus (HPV) is a recent development in the UK. This paper uses an optimal control model to explore how best to target vaccination. We find that the vaccination of sexually active individuals has a greater impact on disease control than the vaccination of sexually non-active individuals. Extending the model to include male vaccination, we find that including males in a vaccination strategy is cost-effective. We compare the optimal control solution to that from a constant control model and show that the optimal control model is more efficient at forcing the system to a disease-controlled steady state.

[1]  I. Frazer,et al.  HPV vaccines: the beginning of the end for cervical cancer. , 2007, Current opinion in immunology.

[2]  Yong Han Kang,et al.  Stability analysis and optimal vaccination of an SIR epidemic model , 2008, Biosyst..

[3]  Jeremy D Goldhaber-Fiebert,et al.  Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling. , 2006, Vaccine.

[4]  Gillian D. Sanders,et al.  Cost Effectiveness of a Potential Vaccine for Human papillomavirus , 2003, Emerging infectious diseases.

[5]  Yun Zou,et al.  Optimal and sub-optimal quarantine and isolation control in SARS epidemics , 2007, Mathematical and Computer Modelling.

[6]  John T. Workman,et al.  Optimal Control Applied to Biological Models , 2007 .

[7]  E. Myers,et al.  Chapter 19: Cost-effectiveness of cervical cancer screening. , 2006, Vaccine.

[8]  W. Fleming,et al.  Deterministic and Stochastic Optimal Control , 1975 .

[9]  Helen Trottier,et al.  The epidemiology of genital human papillomavirus infection. , 2006, Vaccine.

[10]  Dahlard L. Lukes,et al.  Differential Equations: Classical to Controlled , 2012 .

[11]  Petter Ögren,et al.  Vaccination strategies for epidemics in highly mobile populations , 2002, Appl. Math. Comput..

[12]  J. Peto,et al.  Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort , 2004, British Journal of Cancer.

[13]  A. Burchell,et al.  Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. , 2006, Vaccine.

[14]  H. Behncke.  Optimal control of deterministic epidemics , 2000 .

[15]  G. Sanders,et al.  Evaluating Human Papillomavirus Vaccination Programs , 2004, Emerging infectious diseases.

[16]  S. Sethi,et al.  Optimal Control of Some Simple Deterministic Epidemic Models , 1978 .

[17]  Holly Gaff,et al.  Optimal control applied to vaccination and treatment strategies for various epidemiological models. , 2009, Mathematical biosciences and engineering : MBE.

[18]  A. Fiander,et al.  Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. , 2007, Vaccine.

[19]  M. L. Chambers.  The Mathematical Theory of Optimal Processes , 1965 .

[20]  Milton C Weinstein,et al.  Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. , 2004, Journal of the National Cancer Institute.

[21]  L. S. Pontryagin,et al.  Mathematical Theory of Optimal Processes , 1962 .

[22]  Mark Jit,et al.  Economic evaluation of human papillomavirus vaccination in the United Kingdom , 2008, BMJ : British Medical Journal.

[23]  A. Galvani,et al.  Vaccination against multiple HPV types. , 2005, Mathematical biosciences.

[24]  S Gallivan,et al.  Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK , 2006, British Journal of Cancer.

[25]  W. Edmunds,et al.  Cost-effectiveness analyses of human papillomavirus vaccination. , 2007, The Lancet. Infectious diseases.

[26]  A. Shefer,et al.  Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. , 2009, Preventive medicine.